| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |